The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

U.S. Physical Therapy Inc

NYSE: USPH
Last

(U.S.) $68.85

Today's change+0.35 +0.51%
Updated November 17 4:02 PM EST. Delayed by at least 15 minutes.
 

U.S. Physical Therapy Inc

NYSE: USPH
Last

(U.S.) $68.85

Today's change+0.35 +0.51%
Updated November 17 4:02 PM EST. Delayed by at least 15 minutes.

U.S. Physical Therapy Inc up (U.S.)$0.35

U.S. Physical Therapy Inc closed up Friday by (U.S.)$0.35 or 0.51% to (U.S.)$68.85. Over the last five days, shares have gained 0.95%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 7.31% during the last year.

Key company metrics

  • Open(U.S.) $68.05
  • Previous close(U.S.) $68.50
  • High(U.S.) $69.00
  • Low(U.S.) $67.95
  • Bid / Ask-- / --
  • YTD % change-1.92%
  • Volume39,446
  • Average volume (10-day)66,216
  • Average volume (1-month)66,255
  • Average volume (3-month)61,554
  • 52-week range(U.S.) $56.50 to (U.S.) $78.00
  • Beta1.06
  • Trailing P/E49.84×
  • P/E 1 year forward33.23×
  • Forward PEG3.32×
  • Indicated annual dividend(U.S.) $0.80
  • Dividend yield1.16%
  • Trailing EPS(U.S.) $1.38
Updated November 17 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+4.95%

Based on its net profit margin of 4.95%, U.S. Physical Therapy Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.40%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue1031049891
Total other revenue--------
Total revenue1031049891
Gross profit21252119
Total cost of revenue82807772
Total operating expense90898580
Selling / general / administrative8998
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income13161211
Interest income (expense), net non-operating-1-100
Gain (loss) on sale of assets--------
Other--------
Income before tax10980
Income after tax7661
Income tax, total3320
Net income5552
Total adjustments to net income--------
Net income before extra. items5552
Minority interest-1-1-12
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5552
Inc. avail. to common incl. extra. items5552
Diluted net income5552
Dilution adjustment--------
Diluted weighted average shares13131313
Diluted EPS excluding extraordinary itemsvalue per share0.410.390.380.19
Dividends per sharevalue per share0.200.200.200.17
Diluted normalized EPSvalue per share0.410.390.380.20